Analyst Research: Agios Pharmaceuticals Inc (AGIO.O)

AGIO.O on Nasdaq

95.07USD
2:15pm EDT
Change (% chg)

$0.44 (+0.47%)
Prev Close
$94.63
Open
$95.31
Day's High
$96.65
Day's Low
$93.73
Volume
245,331
Avg. Vol
655,032
52-wk High
$138.85
52-wk Low
$31.51

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - AGIOS PHARMACEUTICALS INC (AGIO-O) 5:10am EDT Thomson Reuters Stock Report 11 25.00
Agios Pharmaceuticals, Inc. (AGIO) - Financial Analysis Review 5 May 2015 GlobalData 42 125.00
ValuEngine Industry Report for Medical Products(AGIO) 4 May 2015 ValuEngine, Inc. 10 49.00
ValuEngine Rating and Forecast Report for AGIO 3 May 2015 ValuEngine, Inc. 10 25.00
Agios Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 1 May 2015 Reuters Investment Profile 12 20.00
Value Graph: AGIOS PHARMA -- AGIO 30 Apr 2015 Ford Investor Services, Inc. 1 12.00
TheStreet.com Ratings Stock Report For: AGIOS PHARMACEUTICALS (AGIO) 25 Apr 2015 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

David Schenkein

56 2013 Chief Executive Officer, Director

Duncan Higgons

59 Chief Operating Officer

Shin-San Michael Su

2012 Senior Vice President - research & development

Scott Biller

58 Chief Scientific Officer

Chris Bowden

2014 Chief Medical Officer
Search Stocks